Targeting cancer therapies can take advantage of localized characteristics specific to a given cancer (more commonly a tumor). In the case of targeted therapies against the cancers of given organs, different molecular components can help drugs get delivered to said organs while avoiding other parts of the body (for example targeting the kidney: https://altogen.com/product/kidney-in-vivo-transfection-kit/). This helps reduce side effects from potentially hazardous chemicals while attacking a given tumor.
Targeted therapies block the spread of cancer by interfering with specific molecules ("molecular targets") that are involved in the spread of cancer. Targeted cancer therapies are also called "molecularly targeted drugs," "molecularly targeted therapies," or "precision medicines".
For more information refer to the NIH cancer treatment fact sheet
The well-known cancer treatment has been conventional used is chemotherapy, which designed to kill the rapidly dividing cancer cells and the normal cells.
During the past several years, a new cancer treatment has applied called targeted cancer therapies, which use pharmacological agents that inhibit growth, increase cell death and restrict the spread of cancer, focusing on specific molecular changes which are unique to particular cancer.
I agree with researchers . also, It differs from standard chemotherapy where acts on specific molecular targets that are associated with cancer, whereas most standard chemotherapies act on all rapidly dividing normal and cancerous cells.
Targeted means that it focuses on a particular aspect of the malignancy (such as a cellular pathway) that is potentially aberrant within the cancer cell.
These therapies can be used alongside more traditional therapies to increase their efficacy.
One of the main disadvantages of traditional cancer treatment protocols is that it kills cancer and any rapidly dividing normal cells. Targeted therapy uses a specific functional / genetic change of cancer cells that are acquired during malignant transformation (not found in normal cells) to specifically target those cancer cells. Such therapies mostly use monoclonal antibodies against specific antigen that is found in cancer cells and protects normal ones.
Targeting cancer therapies can take advantage of localized characteristics specific to a given cancer (more commonly a tumor). In the case of targeted therapies against the cancers of given organs, different molecular components can help drugs get delivered to said organs while avoiding other parts of the body (for example targeting the kidney: https://altogen.com/product/kidney-in-vivo-transfection-kit/). This helps reduce side effects from potentially hazardous chemicals while attacking a given tumor.